Human Mesenchymal Stromal Cells Transplantation May Enhance or Inhibit 4T1 Murine Breast Adenocarcinoma through Different Approaches

Figure 7

Primary tumor development in tumor-bearing mice inoculated intraperitoneally with htMSCs. (a) The average tumor volume of G3, G4, and G5 groups in each day is represented. (b) Tumor volumes of individual animals on days 19, 23, and 28. Animals injected with 2 doses of htMSCs showed significantly reduced tumor development compared to untreated control until 23 days after tumor inoculation.

(a)

(b)